Nike earnings top Wall Street’s expectations, despite inflation in the U.S. and Covid lockdowns in China

Nike earnings top Wall Street’s expectations, despite inflation in the U.S. and Covid lockdowns in China


Nike Air Jordan shoes are seen in the store in Krakow, Poland on August 26, 2021.

Jakub Porzycki | Nurphoto | Getty Images

Nike on Monday topped Wall Street’s earnings and sales expectations for the fiscal fourth-quarter, as the sneaker giant overcame a Covid lockdown in China and tougher climate for consumers in the U.S.

Shares rose about 1% in aftermarket trading.

The company did not share a forecast for the year ahead, however. It referred to some ongoing challenges, such as disruptions that have slowed shipments of shoes and apparel across the globe.

Here’s how Nike did in its fiscal fourth quarter compared with what Wall Street was anticipating, based on a survey of analysts by Refinitiv:

  • Earnings per share: 90 cents vs. 81 cents expected
  • Revenue: $12.23 billion vs. $12.06 billion expected

The company reported net income for the three-month period ended May 31 of $1.44 billion, or 90 cents per share, compared with $1.51 billion, or 93 cents per share, a year earlier.

Sales dropped to $12.23 billion from $12.34 billion a year earlier.

Nike is in the middle of a strategy shift, as the company sells more merchandise directly to shoppers and trims back the amount sold by wholesale partners like Foot Locker. Its direct sales grew 7% to $4.8 billion in the quarter versus the year-ago period. Nike’s wholesale business trends were the opposite. Sales in that division dropped 7% to $6.8 billion.

The strategy, which began about two years ago, is paying off, Chief Financial Officer Matt Friend said.

“In this dynamic environment, Nike’s unrivaled strengths continue to fuel our momentum,” he said in a news release, adding that the company is “better positioned than ever to drive long-term growth while serving consumers directly at scale.”

In North America, Nike’s largest market, total sales fell by 5% to $5.11 billion.

In Greater China, its sales took a bigger hit due to lockdowns. Total sales in the country dropped by 19% to $1.56 billion versus $1.93 in the year-ago period.

The athleticwear and sneaker company faces several key challenges in the coming quarters. As the prices of gas, groceries and more rise, some consumers may skip over discretionary items or trade down to lower-priced brands. Supply chain challenges continue, causing merchandise to move slowly around the globe or get stuck in the wrong spot.

In the three-month period, inventory rose to $8.4 billion — up 23% versus the year-ago period — driven by longer lead times from ongoing disruptions in the supply chain.

Shares of Nike closed on Monday at $110.50, down 2.13%. As of Monday’s close, Nike shares are down about 34% so far this year. It’s underperformed the S&P 500, which is down about 18% during the same period. The company’s market value is $173.9 billion.

Nike said its board authorized a new four-year, $18 billion stock buyback program this month. It will replace the company’s $15 billion share buyback program, which will end in the coming fiscal year.

Read the company’s earnings release here.

This story is developing. Please check back for updates.



Source

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Business

Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks

Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Big Food is slimming down. As both consumers and regulators push back against ultra-processed foods, the companies that make them have been splitting […]

Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More